Cytrellis Biosystems

Cytrellis, Inc. – Advancing Aesthetic Medical Technology

Cytrellis Biosystems was founded in 2012, is headquartered in Lexington, United States, lists 11–50 employees, and has $78.5M in recorded funding across 3 rounds.

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$78.5M
Last Round
$50.0M Series CSep 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices. Its ellacor® product uses Micro-Coring® Technology that removes sagging skin on the micro-scale. The system gives aesthetic practitioners an unprecedented ability to improve age-related changes in skin. The company offers FDA-Cleared Micro-Coring® Technology for skin treatment.

Summary

Cytrellis Biosystems is a Biotech company based in Lexington, United States, founded in 2012. It lists 11–50 employees. It has raised $78.5M in total across 3 rounds, most recently a $50.0M Series C round in Sep 2021. Investors include ARCH Venture Partners, D1 Capital Partners and PFM Health Sciences.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2021
$50.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cytrellis Biosystems on Indexed.vc
<a href="https://indexed.vc/companies/cytrellis-biosystems"><img src="https://indexed.vc/api/badge/company/cytrellis-biosystems" alt="Cytrellis Biosystems on Indexed.vc" width="260" height="76" /></a>